Skip to content

Kiniksa Pharmaceuticals International

US · KNSA #1938 by market cap Listed 2018
93.90 +0.36 +0.38%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 5 analysts

Buy
Avg price target 106.20 +13.1%
Price target rangecurrent 93.90
Low98.00
Avg106.20
High122.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-10-30 J.P. Morgan -- Buy 122.00
2026-10-28 CCORF -- Buy 98.00
2026-10-28 Wells Fargo -- Buy 110.00
2026-10-27 Goldman Sachs -- Buy 101.00
2026-10-23 CCORF -- Buy 98.00
2026-10-15 Citi -- Buy 100.00
2026-09-29 Wells Fargo -- Buy 87.00
2026-08-12 CCORF -- Buy 98.00
2026-07-30 Goldman Sachs -- Buy 90.00
2026-07-29 CCORF -- Buy 98.00
2026-07-29 Citi -- Buy 100.00
2026-07-29 J.P. Morgan -- Buy 107.00
2026-07-28 TD Cowen -- Buy 95.00
2026-07-28 Wedbush -- Buy 99.00
2026-07-23 Goldman Sachs -- Buy 75.00
2026-06-29 Wedbush -- Buy 72.00
2026-05-04 J.P. Morgan -- Buy 72.00
2026-04-29 CCORF -- Buy 64.00
2026-04-29 Wells Fargo -- Buy 57.00
2026-04-29 Wedbush -- Buy 59.00
2026-04-29 Citi -- Buy 60.00
2026-04-28 TD Cowen -- Buy 65.00
2026-04-28 Jefferies -- Buy 71.00
2026-04-16 Wedbush -- Buy 58.00
2026-04-14 Wells Fargo -- Buy 53.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-27 -- ±13.35% +22.23% (beat)
2026/Q2 2026-07-28 -- ±10.43% +25.03% (beat)
2026/Q1 2026-04-28 -- ±14.50% +23.48% (beat)
2025/Q4 2026-02-24 -- ±16.08% -8.21% (in line)
2025/Q3 2025-10-28 -- ±13.44% -2.88% (in line)
2025/Q2 2025-07-29 -- ±13.46% +12.32% (in line)
2025/Q1 2025-04-29 -- ±14.08% +20.54% (beat)
2024/Q4 2025-02-25 -- ±15.15% +0.46% (in line)
2024/Q3 2024-10-29 -- ±15.18% -15.68% (beat)
2024/Q2 2024-07-23 -- ±9.98% +22.91% (beat)
2024/Q1 2024-04-23 -- ±15.53% +3.42% (in line)
2023/Q4 2024-02-28 -- ±16.65% -2.54% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.

Kiniksa Pharmaceuticals International discussion 0 comments

Add a comment